Klin Monbl Augenheilkd 2010; 227(4): 349-350
DOI: 10.1055/s-0029-1245255
Der interessante Fall

© Georg Thieme Verlag KG Stuttgart · New York

Unilateral Retinal Emboli in a Patient with Familial Combined Hyperlipidemia

Einseitige retinale Embolien bei einem Patienten mit familiär kombinierter HyperlipidämieP. E. Theoulakis, J. Lepidas, I. K. Petropoulos, A. Livieratou, C. K. Brinkmann, J. M. Katsimpris
Further Information

Publication History





Publication Date:
20 April 2010 (online)

This report aims to describe a patient with undiagnosed familial combined hyperlipidemia (FCH) presenting as outpatient unilateral multiple cholesterol retinal emboli.

References

  • 1 Biousse V, Trobe J D. Transient monocular visual loss.  Am J Ophthalmol. 2005;  140 717-721
  • 2 Brown M, Glassenberg M. Mortality factors in patients with acute stroke.  JAMA. 1973;  224 1493-1495
  • 3 Gaddi A, Cicero A F, Odoo F O. et al . Practical guidelines for familial combined hyperlipidemia diagnosis: an up-date.  Vasc Health Risk Manag. 2007;  3 877-886
  • 4 Klein R, Klein B E, Moss S E. et al . Retinal emboli and cardiovascular disease: the Beaver Dam Eye Study.  Arch Ophthalmol. 2003;  121 1446-1451
  • 5 Messina L M, Sarkar R, Zelenock G B. Cerebrovascular occlusive disease. Greenfield LJ, Mulholland MW, Oldham KT et al Surgery: Scientific Principles and Practice Philadelphia; Lippincott Williams & Wilkins 2001 3rd ed: 1670-1684
  • 6 Perkins E S. The ocular pulse and intraocular pressure as a screening test for carotid artery stenosis.  Br J Ophthalmol. 1985;  69 676-680
  • 7 Russell R W. The source of retinal emboli.  Lancet. 1968;  2 789-792
  • 8 Sniderman A D, Castro Cabezas M, Ribalta J. et al . A proposal to redefine familial combined hyperlipidemia – third workshop on FCHL held in Barcelona from 3 to 5 May 2001, during the scientific sessions of the European Society for Clinical Investigation.  Eur J Clin Invest. 2002;  32 71-73
  • 9 Sniderman A D, Furberg C D, Keech A. et al . Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment.  Lancet. 2003;  361 777-780

John M. Katsimpris, MD, PhD

Department of Ophthalmology, General Hospital of Patras ”Agios Andreas”

Ritsou & Empeirikou Street 73

GR-26335 Patras, Greece

Phone: ++ 30/26 10/64 34 97 , ++ 30/6 93/6 95 09 50

Fax: ++ 30/26 10/64 34 97

Email: jkatsimpris@yahoo.com

    >